Work

A bioinformatic approach to understanding genome-level amplifications in glioblastoma

Year: 2015
Type: article
Abstract: Glioblastoma is the most common and deadly primary brain tumor that occurs in adults.It is characterized by acute onset and rapid progression, typically resulting in patient death within 15 months of diagnosis.Unfortunately, very few effective treatment options have been uncovered despite substantial scientific efforts in the field.One negative prognostic factor that has been associated with the most aggressive and fatal GBMs is gene amplification of epidermal growth factor receptor (EGFR).Prior to the advent of paired-end next generation sequencing, it was exceedingly difficult to determine the genomic structure of amplicons containing the EGFR gene much less ascertain the underlying mechanisms responsible for their formation.In recent years, studies utilizing breakpoint mapping of whole genome paired-end sequencing (WGS) have been able to resolve translocations in tumor cells that affect oncogenic progression at the single nucleotide level.This has led to numerous breakthroughs in the detection of structural variants that lead to gene duplication, deletion, loss of heterozygosity and even the creation of fusion genes.In light of these breakthroughs, we decided to leverage the power of WGS analysis in order to identify clinically relevant oncogenic features of GBM.These studies have resulted in two publications that ultimately clarify and challenge the currently held conceptions of GBM initiation and progression.In our first study, we sought to identify genomic structural variations that lead to enhanced EGFR signaling using a solely bioinformatic approach.To this end, we created a custom bioinformatic analysis pipeline and were able to show, in our limited sample size of ten patients, four distinct mechanisms that had only previously been described using a combination of histological and traditional genetic techniques.This study provided us with valuable experience and emphasized the viability of this analysis in the interpretation of genomic structural variance.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W2534858178
FWCI:
Cites: 101
Cited by:
Related to: 10